Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1998-06-02
Tsang, Cecilia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 14, 514 15, 514 16, 514 17, 530317, 530324, 530325, 530326, 530327, 530328, 530329, 530330, A61K 3800, A61K 3812, C07K 500, C07K 700
Patent
active
057599947
ABSTRACT:
The DNA encoding the cell surface receptor for thrombin has been cloned and sequenced. The availability of this DNA permits the recombinant production of thrombin receptor which can be produced at cell surfaces and is useful in assay systems both for the detection of thrombin and for the evaluation of candidate thrombin agonists and antagonists. Further, the elucidation of the structure of the thrombin receptor permits the design of agonist and antagonist compounds which are useful diagnostically and therapeutically. The availability of the thrombin receptor also permits production of antibodies specifically immunoreactive with the receptor per se or with specific regions thereof which are also useful diagnostically or therapeutically.
REFERENCES:
patent: 4783330 (1988-11-01), Furie
patent: 4859609 (1989-08-01), Dull et al.
patent: 5132408 (1992-07-01), Moezie
patent: 5256766 (1993-10-01), Coughlin
Berliner, et al., Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding of glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivitiy is conferred by Pro 1743 and other amino, 1988.
Layton, et al., Epitope mapping of human granulocyte-macrophage colony stimulating factor (hGM-CSF), UCLA Symp. Mol. Cell. Biol., New Ser., 120 (Hematopoiesis), pp. 11-21, 1990.
Francis, Robert, Neurotoxicity in mice of Tat protein cysteine-rich sequences of visna virus and HIV-1, C.R. Acad. Sci. , Ser. 3, vol. 311(4), pp. 149-155, 1990.
Mascotti, et al., Thermodynamic extent of counterion relase upon binding oligolysines to single-stranded nucleic acids, Proc. Natl. Acad. Sci. U.S.A., vol. 87(8), pp. 3142-3146, 1990.
Baniyash et al., J. Biol. Chem., vol. 264, pp. 13252-13257 (1989).
Bar-Shavit et al., Journal of Cell Biology, vol. 112(2), pp. 335-344 (1991).
Berndt et al., Elsevier/North Holland Biomedical Press, pp. 43-74, "Platelets in Biology and Pathology" (1981).
Bode et al., EMBO Journal, vol. 8, pp. 3467-3475 (1989).
Greco et al., Blood, vol. 75, pp. 1983-1990 (1990).
Gronke et al., J. Biol. Chem., vol. 262, pp. 3030-3036 (1987).
Martin et al., Biochem., vol. 14, pp. 1308-1314 (1975).
Okamura et al., J. Biol. Chem., vol. 253, p. 3435 (1978).
Phillips, Thrombin Diath. Haemorrh., vol.32, pp. 207-215 (1974).
Pipili-Synetos et al., Biochem. Biophys. Res. Comm., vol. 171, pp. 913-919 (1990).
Tollefsen et al., J. Biol. Chem., vol. 249, pp. 2646-2651 (1974).
Ruda et al., Biochemical Pharmacology, vol. 39(2), pp. 373-381 (1990).
Ruda et al., Annals. New York Academy of Sciences, vol. 485, pp. 439-442 (1986).
Ruda et al., Biochemical Pharmacology, vol. 37(12), pp. 2417-2426 (1988).
Van Obberghen-Shilling et al., FEBS Letters, vol. 262, pp. 330-334 (1990).
Vu et al., Nature, vol. 353, pp. 674-677 (1991).
Vu et al., Cell, vol. 64, pp. 1057-1058 (1991).
Walz et al., Annals. New York Academy of Sciences, vol. 485, pp. 323-334 (1986).
D. Cosman, DNA and Protein Engineering Techniques, vol. 2, No. 1, pp. 1-3 (1990).
Edgington, Biotechnology, vol. 10, pp. 383-389 (1992).
Foster et al., id., vol. 82, pp. 4673-4677 (1985).
Frost et al., J. Cell. Biol., vol. 105, pp. 2551-2558 (1987).
Gearing et al., EMBO Journal, vol. 8, pp. 3667-3676 (1989).
Hui et al., BBRC, vol. 184, pp. 790-796 (1992).
Jackman et al., Proc. Natl. Acad. Sci., vol. 84, pp. 6425-6429 (1987).
Masu et al., Nature, vol. 329, pp. 836-838 (1987).
Rasmussen et al., FEBS Letters, vol. 288, pp. 123-128 (1991).
Sambrook et al., Molecular Cloning, 2nd edition, Cold Spring Harbor (NY) Press, Ch. 12.
Sambrook et al., op. cit., pp. 11.2-11.8.
Scarborough et al., J. Biol. Chem., vol. 267, pp. 13146-13149 (1992).
Seed et al., id., vol. 84, pp. 3365-3369 (1987).
Sevier, Clin. Chem., vol. 27, pp. 1797-1806 (1981).
Suzuki, Acta. Haematol., vol. 51, pp. 1655-1664 (1988).
Watson et al., Recombinant DNA, 2nd ed., New York, Scientific American, p. 108.
Yamamoto et al., Thrombosis and Haemostasis, vol. 55(2), pp. 162-167 (1986).
Young et al., Proc. Natl. Acad. Sci. USA, vol. 80, pp. 1194-1198 (1983).
Coughlin Shaun R.
Scarborough Robert M.
COR Therapeutics
Harle Jennifer
The Regents of the University of California
Tsang Cecilia L.
LandOfFree
Recombinant thrombin receptor and related pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant thrombin receptor and related pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant thrombin receptor and related pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1459772